Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Dermatology Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Dermatology Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Dermatology Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Pfizer
GlaxoSmithKline
AbbVie
Merz Pharma
LEO Pharma
Valeant
Johnson & Johnson
Bristol-Myers Squibb
Bayer
Novartis
Galderma
By Type:
External Use
Oral
Injection
By End-User:
Psoriasis
Skin Infections
Acne
Dermatitis
Other
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Dermatology Drugs Market
-
1.3 Market Segment by Type
1.3.1 Japan Dermatology Drugs Market Size and Growth Rate of External Use from 2014 to 2026
1.3.2 Japan Dermatology Drugs Market Size and Growth Rate of Oral from 2014 to 2026
1.3.3 Japan Dermatology Drugs Market Size and Growth Rate of Injection from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Dermatology Drugs Market Size and Growth Rate of Psoriasis from 2014 to 2026
1.4.2 Japan Dermatology Drugs Market Size and Growth Rate of Skin Infections from 2014 to 2026
1.4.3 Japan Dermatology Drugs Market Size and Growth Rate of Acne from 2014 to 2026
1.4.4 Japan Dermatology Drugs Market Size and Growth Rate of Dermatitis from 2014 to 2026
1.4.5 Japan Dermatology Drugs Market Size and Growth Rate of Other from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Dermatology Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Dermatology Drugs by Major Types
3.4.1 Market Size and Growth Rate of External Use
3.4.2 Market Size and Growth Rate of Oral
3.4.3 Market Size and Growth Rate of Injection
4 Segmentation of Dermatology Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Dermatology Drugs by Major End-Users
4.4.1 Market Size and Growth Rate of Dermatology Drugs in Psoriasis
4.4.2 Market Size and Growth Rate of Dermatology Drugs in Skin Infections
4.4.3 Market Size and Growth Rate of Dermatology Drugs in Acne
4.4.4 Market Size and Growth Rate of Dermatology Drugs in Dermatitis
4.4.5 Market Size and Growth Rate of Dermatology Drugs in Other
5 Market Analysis by Regions
-
5.1 Japan Dermatology Drugs Production Analysis by Regions
-
5.2 Japan Dermatology Drugs Consumption Analysis by Regions
6 Hokkaido Dermatology Drugs Landscape Analysis
-
6.1 Hokkaido Dermatology Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Dermatology Drugs Landscape Analysis by Major End-Users
7 Tohoku Dermatology Drugs Landscape Analysis
-
7.1 Tohoku Dermatology Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Dermatology Drugs Landscape Analysis by Major End-Users
8 Kanto Dermatology Drugs Landscape Analysis
-
8.1 Kanto Dermatology Drugs Landscape Analysis by Major Types
-
8.2 Kanto Dermatology Drugs Landscape Analysis by Major End-Users
9 Chubu Dermatology Drugs Landscape Analysis
-
9.1 Chubu Dermatology Drugs Landscape Analysis by Major Types
-
9.2 Chubu Dermatology Drugs Landscape Analysis by Major End-Users
10 Kinki Dermatology Drugs Landscape Analysis
-
10.1 Kinki Dermatology Drugs Landscape Analysis by Major Types
-
10.2 Kinki Dermatology Drugs Landscape Analysis by Major End-Users
11 Chugoku Dermatology Drugs Landscape Analysis
-
11.1 Chugoku Dermatology Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Dermatology Drugs Landscape Analysis by Major End-Users
12 Shikoku Dermatology Drugs Landscape Analysis
-
12.1 Shikoku Dermatology Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Dermatology Drugs Landscape Analysis by Major End-Users
13 Kyushu Dermatology Drugs Landscape Analysis
-
13.1 Kyushu Dermatology Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Dermatology Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Pfizer
14.1.1 Pfizer Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 GlaxoSmithKline
14.2.1 GlaxoSmithKline Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 AbbVie
14.3.1 AbbVie Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Merz Pharma
14.4.1 Merz Pharma Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 LEO Pharma
14.5.1 LEO Pharma Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Valeant
14.6.1 Valeant Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Johnson & Johnson
14.7.1 Johnson & Johnson Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Bristol-Myers Squibb
14.8.1 Bristol-Myers Squibb Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Bayer
14.9.1 Bayer Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Novartis
14.10.1 Novartis Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Galderma
14.11.1 Galderma Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
The List of Tables and Figures (Totals 96 Figures and 169 Tables)
Figure Japan Dermatology Drugs Market Size and Growth Rate of External Use from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Oral from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Injection from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Psoriasis from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Skin Infections from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Acne from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Dermatitis from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Other from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Dermatology Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Dermatology Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Dermatology Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Dermatology Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Dermatology Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of External Use
Figure Market Size and Growth Rate of Oral
Figure Market Size and Growth Rate of Injection
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Dermatology Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Dermatology Drugs by Different End-Users from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Psoriasis from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Skin Infections from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Acne from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Dermatitis from 2014 to 2026
Figure Japan Dermatology Drugs Market Size and Growth Rate of Other from 2014 to 2026
-
Table Japan Dermatology Drugs Production by Regions
-
Table Japan Dermatology Drugs Production Share by Regions
-
Figure Japan Dermatology Drugs Production Share by Regions in 2014
-
Figure Japan Dermatology Drugs Production Share by Regions in 2018
-
Figure Japan Dermatology Drugs Production Share by Regions in 2026
-
Table Japan Dermatology Drugs Consumption by Regions
-
Table Japan Dermatology Drugs Consumption Share by Regions
-
Figure Japan Dermatology Drugs Consumption Share by Regions in 2014
-
Figure Japan Dermatology Drugs Consumption Share by Regions in 2018
-
Figure Japan Dermatology Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Dermatology Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Dermatology Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Dermatology Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Dermatology Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Dermatology Drugs Consumption Share by Types in 2026
-
Table Hokkaido Dermatology Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Dermatology Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Dermatology Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Dermatology Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Dermatology Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Dermatology Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Dermatology Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Dermatology Drugs Consumption Share by Types in 2014
-
Figure Tohoku Dermatology Drugs Consumption Share by Types in 2018
-
Figure Tohoku Dermatology Drugs Consumption Share by Types in 2026
-
Table Tohoku Dermatology Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Dermatology Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Dermatology Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Dermatology Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Dermatology Drugs Consumption Share by End-Users in 2026
-
Table Kanto Dermatology Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Dermatology Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Dermatology Drugs Consumption Share by Types in 2014
-
Figure Kanto Dermatology Drugs Consumption Share by Types in 2018
-
Figure Kanto Dermatology Drugs Consumption Share by Types in 2026
-
Table Kanto Dermatology Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Dermatology Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Dermatology Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Dermatology Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Dermatology Drugs Consumption Share by End-Users in 2026
-
Table Chubu Dermatology Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Dermatology Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Dermatology Drugs Consumption Share by Types in 2014
-
Figure Chubu Dermatology Drugs Consumption Share by Types in 2018
-
Figure Chubu Dermatology Drugs Consumption Share by Types in 2026
-
Table Chubu Dermatology Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Dermatology Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Dermatology Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Dermatology Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Dermatology Drugs Consumption Share by End-Users in 2026
-
Table Kinki Dermatology Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Dermatology Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Dermatology Drugs Consumption Share by Types in 2014
-
Figure Kinki Dermatology Drugs Consumption Share by Types in 2018
-
Figure Kinki Dermatology Drugs Consumption Share by Types in 2026
-
Table Kinki Dermatology Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Dermatology Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Dermatology Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Dermatology Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Dermatology Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Dermatology Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Dermatology Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Dermatology Drugs Consumption Share by Types in 2014
-
Figure Chugoku Dermatology Drugs Consumption Share by Types in 2018
-
Figure Chugoku Dermatology Drugs Consumption Share by Types in 2026
-
Table Chugoku Dermatology Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Dermatology Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Dermatology Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Dermatology Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Dermatology Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Dermatology Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Dermatology Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Dermatology Drugs Consumption Share by Types in 2014
-
Figure Shikoku Dermatology Drugs Consumption Share by Types in 2018
-
Figure Shikoku Dermatology Drugs Consumption Share by Types in 2026
-
Table Shikoku Dermatology Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Dermatology Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Dermatology Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Dermatology Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Dermatology Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Dermatology Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Dermatology Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Dermatology Drugs Consumption Share by Types in 2014
-
Figure Kyushu Dermatology Drugs Consumption Share by Types in 2018
-
Figure Kyushu Dermatology Drugs Consumption Share by Types in 2026
-
Table Kyushu Dermatology Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Dermatology Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Dermatology Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Dermatology Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Dermatology Drugs Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of AbbVie
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
Figure Sales and Growth Rate Analysis of AbbVie
Figure Revenue and Market Share Analysis of AbbVie
Table Product and Service Introduction of AbbVie
Table Company Profile and Development Status of Merz Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharma
Figure Sales and Growth Rate Analysis of Merz Pharma
Figure Revenue and Market Share Analysis of Merz Pharma
Table Product and Service Introduction of Merz Pharma
Table Company Profile and Development Status of LEO Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LEO Pharma
Figure Sales and Growth Rate Analysis of LEO Pharma
Figure Revenue and Market Share Analysis of LEO Pharma
Table Product and Service Introduction of LEO Pharma
Table Company Profile and Development Status of Valeant
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant
Figure Sales and Growth Rate Analysis of Valeant
Figure Revenue and Market Share Analysis of Valeant
Table Product and Service Introduction of Valeant
Table Company Profile and Development Status of Johnson & Johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
Figure Sales and Growth Rate Analysis of Johnson & Johnson
Figure Revenue and Market Share Analysis of Johnson & Johnson
Table Product and Service Introduction of Johnson & Johnson
Table Company Profile and Development Status of Bristol-Myers Squibb
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
Table Product and Service Introduction of Bristol-Myers Squibb
Table Company Profile and Development Status of Bayer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
Figure Sales and Growth Rate Analysis of Bayer
Figure Revenue and Market Share Analysis of Bayer
Table Product and Service Introduction of Bayer
Table Company Profile and Development Status of Novartis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
Figure Sales and Growth Rate Analysis of Novartis
Figure Revenue and Market Share Analysis of Novartis
Table Product and Service Introduction of Novartis
Table Company Profile and Development Status of Galderma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galderma
Figure Sales and Growth Rate Analysis of Galderma
Figure Revenue and Market Share Analysis of Galderma
Table Product and Service Introduction of Galderma
-
